This meta-analysis provides robust evidence that inflammatory biomarkers, particularly IL-6, IL-10, IL-8, and S100B, are significantly elevated in patients with COVID-19 pneumonia and organ failure compared to non-pneumonia COVID-19 patients and healthy controls. This evidence concerns the gene IL6 and COVID-19.